NOCARH syndrome (neonatal onset of cytopenia, autoinflammation, rash, and episodes of hemophagocytic lymphohistiocytosis [HLH]) is an extremely rare syndrome characterized by neonatal onset pancytopenia / dyshematopoiesis, autoinflammation, rash, and HLH. It is caused by a mutation in the cell division cycle 42 (CDC42) protein, usually in p. R186C at the C-terminal. CDC42 is responsible for ensuring proper functioning of the cell cycle, as well as cellular proliferation, adhesion, and migration. Thus, mutation in this protein causes dysregulated cell functioning, including hematological cell lines in the bone marrow. Most patients diagnosed with NOCARH syndrome have no family history. A single family with a recessively inherited mutation has been reported.
This syndrome presents with fever, rash, failure to thrive, hepatosplenomegaly, diarrhea, pancytopenia, and HLH starting in infancy. NOCARH syndrome is a fatal disease if not treated promptly; many pediatric patients have not survived this disease even with treatment.
Emergency: requires immediate attention
NOCARH syndrome
Alerts and Notices
Important News & Links
Synopsis
Codes
ICD10CM:
D61.818 – Other pancytopenia
D76.1 – Hemophagocytic lymphohistiocytosis
D76.3 – Other histiocytosis syndromes
M04.8 – Other autoinflammatory syndromes
SNOMEDCT:
234437005 – Hemophagocytic lymphohistiocytosis
D61.818 – Other pancytopenia
D76.1 – Hemophagocytic lymphohistiocytosis
D76.3 – Other histiocytosis syndromes
M04.8 – Other autoinflammatory syndromes
SNOMEDCT:
234437005 – Hemophagocytic lymphohistiocytosis
Look For
Subscription Required
Diagnostic Pearls
Subscription Required
Differential Diagnosis & Pitfalls
To perform a comparison, select diagnoses from the classic differential
Subscription Required
Best Tests
Subscription Required
Management Pearls
Subscription Required
Therapy
Subscription Required
References
Subscription Required
Last Reviewed:01/12/2022
Last Updated:01/24/2022
Last Updated:01/24/2022